BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30926837)

  • 1. Monocytes/Macrophages play a pathogenic role in IL-23 mediated psoriasis-like skin inflammation.
    Wang Y; Edelmayer R; Wetter J; Salte K; Gauvin D; Leys L; Paulsboe S; Su Z; Weinberg I; Namovic M; Gauld SB; Honore P; Scott VE; McGaraughty S
    Sci Rep; 2019 Mar; 9(1):5310. PubMed ID: 30926837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Modulation of Monocytes Dampens the IL-17
    Pinget GV; Tan J; Niewold P; Mazur E; Angelatos AS; King NJC; Macia L
    J Invest Dermatol; 2020 Dec; 140(12):2398-2407.e1. PubMed ID: 32389535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis.
    Senra L; Stalder R; Alvarez Martinez D; Chizzolini C; Boehncke WH; Brembilla NC
    J Invest Dermatol; 2016 Oct; 136(10):1970-1980. PubMed ID: 27329229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
    Morimura S; Oka T; Sugaya M; Sato S
    J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of psoriasiform dermatitis induced by systemic injection of interleukin-23 minicircles in mice.
    Leys L; Wang Y; Paulsboe S; Edelmayer R; Salte K; Wetter J; Namovic M; Phillips L; Dunstan R; Gauvin D; Donnelly-Roberts D; Su Z; Honore P; McGaraughty S
    J Dermatol; 2019 Jun; 46(6):482-497. PubMed ID: 31062408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells.
    Noack M; Ndongo-Thiam N; Miossec P
    Clin Exp Immunol; 2016 Oct; 186(1):64-74. PubMed ID: 27328392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of autoinflammation in early-phase psoriasis.
    Fanoni D; Venegoni L; Vergani B; Tavecchio S; Cattaneo A; Leone BE; Berti E; Marzano AV
    Clin Exp Immunol; 2019 Dec; 198(3):283-291. PubMed ID: 31509228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis.
    Yawalkar N; Tscharner GG; Hunger RE; Hassan AS
    J Dermatol Sci; 2009 May; 54(2):99-105. PubMed ID: 19264456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.
    Ippagunta SK; Gangwar R; Finkelstein D; Vogel P; Pelletier S; Gingras S; Redecke V; Häcker H
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6162-E6171. PubMed ID: 27671649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulated Caveolin-1 expression in circulating monocytes may contribute to the pathogenesis of psoriasis.
    Takamura N; Yamaguchi Y; Watanabe Y; Asami M; Komitsu N; Aihara M
    Sci Rep; 2019 Jan; 9(1):125. PubMed ID: 30644419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
    Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
    Front Immunol; 2018; 9():200. PubMed ID: 29535706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis.
    Djemadji-Oudjiel N; Goerdt S; Kodelja V; Schmuth M; Orfanos CE
    Arch Dermatol Res; 1996 Nov; 288(12):757-64. PubMed ID: 8950456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A induces heterogeneous macrophages, and it does not alter the effects of lipopolysaccharides on macrophage activation in the skin of mice.
    Nakai K; He YY; Nishiyama F; Naruse F; Haba R; Kushida Y; Katsuki N; Moriue T; Yoneda K; Kubota Y
    Sci Rep; 2017 Sep; 7(1):12473. PubMed ID: 28963556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in Understanding the Immunological Pathways in Psoriasis.
    Georgescu SR; Tampa M; Caruntu C; Sarbu MI; Mitran CI; Mitran MI; Matei C; Constantin C; Neagu M
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30744173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.